Nordea Investment Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.12M | Buy |
355,000
+5,400
| +2% | +$47.4K | ﹤0.01% | 650 |
|
|
2025
Q1 | $2.81M | Buy |
349,600
+11,000
| +3% | +$88.6K | ﹤0.01% | 639 |
|
|
2024
Q4 | $3.05M | Buy |
338,600
+1,000
| +0.3% | +$9.01K | ﹤0.01% | 620 |
|
|
2024
Q3 | $2.5M | Sell |
337,600
-12,300
| -4% | -$91.1K | ﹤0.01% | 654 |
|
|
2024
Q2 | $1.95M | Buy |
349,900
+41,400
| +13% | +$231K | ﹤0.01% | 702 |
|
|
2024
Q1 | $1.55M | Buy |
308,500
+105,100
| +52% | +$529K | ﹤0.01% | 749 |
|
|
2023
Q4 | $1.86M | Sell |
203,400
-11,100
| -5% | -$101K | ﹤0.01% | 723 |
|
|
2023
Q3 | $1.69M | Buy |
214,500
+2,100
| +1% | +$16.5K | ﹤0.01% | 723 |
|
|
2023
Q2 | $2.12M | Buy |
+212,400
| New | +$2.12M | ﹤0.01% | 690 |
|